- All Journals
- Al-Qadisiyah University
- Basrah University
- Kirkuk University
- Mosul University
- The Iraqi Borad for Medical Specialization
- University of Anbar
- University of Technology
- Al Mustafa University
- Al-Zahraa University for Women
- Alnoor University
- Kunooz University
- Misan University
- Ninevah University
- Tikrit University
- University of Al-Hamdaniya
- University of Kerbala
Effects of metformin on the lipid profllein polycystic ovarian syndrome patients | ||
| Iraqi Journal of Embryos and Infertility Researches | ||
| Article 1, Volume 1, Issue 2, 2011, Pages 13-17 | ||
| Abstract | ||
| Polycystic ovary syndrome (PCOS) is (be most common and prevalent endocrinopathy in women , and the most common cause of anovulatory infertility- An altered lipid profile is common in polycystic ovary syndrome (PCOS) and is usually characterized by increased total cholesterol, triglycerides, low-density lipoproteins and very low density lipoprotein levels with low high-density lipoprotein. PCOS is associated wth a higher frequency of card Avascular disease because of dyslipidemia. Which are potent markers for cardiovascular risk factors. Metformin, is a widely used antihypenglycemic agent It decreases insulin resistance and reduces hyperglycemia through a reduction of the hepaticglucose production. Objectives Determine Ihe beneficial effect of metformin in PCOS paliente in reducing lipid profile and subsequently reduction incardiovasculardisease. Hctbod Measurements and anaiysis levels of total cholesterol, triglycerides, taw-density lipoproteins, very low density lipoprotein and high-density lipoprotein were samples collected at the Institute of embryo research and infertility treatment. Al-Nahnain Univereity, PCOS patients were recruited at the consultant clinic Patients: forty three women with PCOS were studied. Anthropometric data, Jipki profile, were evaluated, before oral metformffi (50Qmg'twioedaify}treatinent and aflerthree months of use. Patients with PCOS after oral metformin treatment, revealed a sign ificant lowering serum concentrations of totat cholesterol, triglyceride, taw-density lipoproteins and very low density Apoprotein and elevated high- density lipoprotein compared to before treatment. cdqcbttkms dyslipidemia is common finding in PCOS women, in this study we found that the use of oral metformin tablets 500mg/ twioe daily fcrthree months will correct lipid profile level (cholesterol triglyceride, LDL, VLDL and HDL) which is considered as caidiovascular risk factors and this lead to reduce risk of cardiovascular diseases. | ||
| Keywords | ||
| Polycysticovarian syndrome; lipid profile and metformin | ||
|
Statistics Article View: 39 PDF Download: 4 |
||